Mitigating Paxlovid™-induced drug‒drug interaction toxicity: an in silico insight

• Autores principales: Giang H. Ta (Autor), Max K. Leong (Autor)
• Formato: Libro
• Publicado: Frontiers Media S.A., 2024-11-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

The clinical drug-drug interaction side-effects of Ritonavir, an ingredient in Paxlovid™, have been documented, highlighting the need to explore alternative administration methods for Nirmatrelvir, another drug in the Paxlovid™ combination. In this study, the skin permeability potential of Nirmatrel...